| Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to … LK Brents, A Gallus-Zawada, A Radominska-Pandya, T Vasiljevik, ... Biochemical pharmacology 83 (7), 952-961, 2012 | 197 | 2012 |
| Repeated administration of phytocannabinoid Δ9-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and … S Tai, WS Hyatt, C Gu, LN Franks, T Vasiljevik, LK Brents, PL Prather, ... Pharmacological research 102, 22-32, 2015 | 57 | 2015 |
| Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse T Vasiljevik, LN Franks, BM Ford, JT Douglas, PL Prather, WE Fantegrossi, ... Journal of medicinal chemistry 56 (11), 4537-4550, 2013 | 50 | 2013 |
| Semisynthetic neoclerodanes as kappa opioid receptor probes KM Lovell, T Vasiljevik, JJ Araya, A Lozama, KM Prevatt-Smith, VW Day, ... Bioorganic & medicinal chemistry 20 (9), 3100-3110, 2012 | 39 | 2012 |
| Cannabinoid 2 receptor-and beta Arrestin 2-dependent upregulation of serotonin 2A receptors JM Franklin, T Vasiljevik, TE Prisinzano, GA Carrasco European Neuropsychopharmacology 23 (7), 760-767, 2013 | 29 | 2013 |
| Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT2A receptors JM Franklin, T Vasiljevik, TE Prisinzano, GA Carrasco Pharmacological research 68 (1), 46-58, 2013 | 29 | 2013 |
| Studies toward the development of antiproliferative neoclerodanes from salvinorin A T Vasiljevik, CE Groer, K Lehner, H Navarro, TE Prisinzano Journal of natural products 77 (8), 1817-1824, 2014 | 14 | 2014 |
| Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist/CB2R agonist aminoalkylindole derivatives in mice S Tai, T Vasiljevik, AM Sherwood, S Eddington, CD Wilson, TE Prisinzano, ... Drug and alcohol dependence 192, 285-293, 2018 | 8 | 2018 |
| Tolerance and cross‐tolerance among high‐efficacy synthetic cannabinoids JWH‐018 and JWH‐073 and low‐efficacy phytocannabinoid Δ9‐THC WE Fantegrossi, LN Franks, T Vasiljevik, PL Prather The FASEB Journal 27, 1097.1-1097.1, 2013 | 1 | 2013 |
| Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases PL Prather, TE Prisinzano, WE Fantegrossi, LK Brents, J Moran, ... US Patent 9,416,103, 2016 | | 2016 |
| Design and Synthesis of Novel CNS Biological Probes T Vasiljevik University of Kansas, 2013 | | 2013 |
